Mark Schroeder, MD

Mark Schroeder, MD

Bone Marrow Transplant Specialist, Medical Oncologist

Primary Academic Title

Associate Professor of Medicine, Division of Oncology, Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine

Clinical Expertise

As a member of our myelodysplastic syndromes specialist team, Dr. Schroeder cares for patients diagnosed with these syndromes through treatment and recovery. Learn more about Dr. Schroeder and the Blood and Marrow Transplant Program at Siteman.

Research Interest

Transplant biology and the development of novel therapeutics and treatment approaches for myelodysplastic syndrome and leukemia. My research in transplant biology includes improving stem cell mobilization and understanding and improving treatment of graft-versus-host disease. My clinical research interest includes hematologic malignancies such as MDS, AML and CLL and their treatment by hematopoietic stem cell transplantation and the development of new treatment approaches.


  • 2003: MD, University of Cincinnati
  • 2012: MS, clinical investigation, Washington University, St. Louis


  • 2003 - 2004: Intern, internal medicine, Washington University, St. Louis
  • 2004 - 2006: Resident, internal medicine, Washington University
  • 2006 - 2009: Fellow, hematology and oncology, Washington University

Board Certification

  • 2006: American Board of Internal Medicine, Internal Medicine
  • 2009: American Board of Internal Medicine, Medical Oncology
  • 2010: American Board of Internal Medicine, Hematology

Selected Research Publications

Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
  • Kumar SK, Callander NS, Adekola K, [...] Schroeder MA, [...] Kumar R
  • J Natl Compr Canc Netw 2024
Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
  • Kumar SK, Callander NS, Adekola K, [...] Schroeder MA, [...] Snedeker J
  • J Natl Compr Canc Netw 2023
Acute Graft-versus-Host Disease: An Update on New Treatment Options.
  • Patel DA, Crain M, Pusic I, Schroeder MA
  • Drugs 2023
NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022.
  • Saad A, Loren A, Bolaños-Meade J, [...] Schroeder M, [...] Pluchino LA
  • J Natl Compr Canc Netw 2023
Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy.
  • Ferraro F, Gruszczynska A, Ruzinova MB, [...] Schroeder MA, [...] Welch JS
  • Haematologica 2022
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy.
  • Berrien-Elliott MM, Becker-Hapak M, Cashen AF, [...] Schroeder MA, [...] Fehniger TA
  • Blood 2022
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia.
  • Berrien-Elliott MM, Foltz JA, Russler-Germain DA, [...] Schroeder MA, [...] Fehniger TA
  • Sci Transl Med 2022
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis.
  • Gooptu M, Romee R, St Martin A, [...] Schroeder MA, [...] Eapen M
  • Blood 2021

View All Publications

Contact Information

  • Washington University Medical Campus

    4921 Parkview Place
    Saint Louis, MO 63110

  • Illinois

    1418 Cross St.
    Shiloh, IL 62269

Phone Numbers

Request an appointment